A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
Recreational use of synthetic cannabinoids (SCs), also known as “K2” or “Spice,” is becoming a major public-health concern due to their potential for abuse and harmful consequences. New substances are constantly being added to the content of SCs. The dearth of information on these newly added conten...
Saved in:
Main Authors: | Osamah Hasan, Ankit A. Patel, James J. Siegert |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/6327819 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gross Hematuria and Hemolytic Anemia in Infectious Mononucleosis
by: Chinmayi Sharma, et al.
Published: (2024-01-01) -
Gross Hematuria following SARS-CoV-2 Vaccination
by: Maryam Sattari, et al.
Published: (2023-01-01) -
Gross Hematuria and Bladder Tumor in a Patient with Advanced Thyroid Papillary Carcinoma
by: Takao Ando, et al.
Published: (2013-01-01) -
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
by: Jose Orsini, et al.
Published: (2015-01-01) -
Brugada Phenocopy Type 1 Secondary to Synthetic Cannabinoids
by: Mohammad Amro, et al.
Published: (2020-01-01)